Skip to content

Clinical trials

Phase 3 Major Depressive Disorder trials in Romania

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Major Depressive Disorder Phase: Phase 3 Country / region: Romania Clear all

24 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20053
20063
20071
20081
20091
20102
20114
20122
20131
20242
20253
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed16
Recruiting4
Terminated3
Active, not recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
AstraZeneca4
Janssen Research & Development, LLC3
Otsuka Pharmaceutical Development & Commercialization, Inc.3
Corcept Therapeutics2
Neurocrine Biosciences2
Shire2
Aziende Chimiche Riunite Angelini Francesco S.p.A1
Eli Lilly and Company1
H. Lundbeck A/S1
Pfizer1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Major Depressive Disorder24
Depressive Disorder3
Mental Disorders2
Mood Disorders2
Psychotic Disorders2
Anhedonia1
Depressive Disorder, Treatment-Resistant1
Sleep Initiation and Maintenance Disorders1

Trials

Showing 1 to 24 of 24. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.